LABS.TO
Medipharm Labs Corp
Price:  
0.09 
CAD
Volume:  
35,300.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LABS.TO WACC - Weighted Average Cost of Capital

The WACC of Medipharm Labs Corp (LABS.TO) is 9.1%.

The Cost of Equity of Medipharm Labs Corp (LABS.TO) is 8.95%.
The Cost of Debt of Medipharm Labs Corp (LABS.TO) is 11.65%.

Range Selected
Cost of equity 7.80% - 10.10% 8.95%
Tax rate 1.30% - 4.00% 2.65%
Cost of debt 7.00% - 16.30% 11.65%
WACC 7.7% - 10.5% 9.1%
WACC

LABS.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.91 0.98
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.80% 10.10%
Tax rate 1.30% 4.00%
Debt/Equity ratio 0.06 0.06
Cost of debt 7.00% 16.30%
After-tax WACC 7.7% 10.5%
Selected WACC 9.1%